Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07046351 · ClinicalTrials.gov registry record · NA
weSIPsmarter: Evaluating a Digital Health Intervention Aimed at Reducing Sugary Drinks Among Rural Head Start Preschoolers and Their Parents
A NA study of Sugary Beverages, sponsored by University of Virginia.
- Recruiting
- Registry status
- NA
- Development phase
- 744
- Enrollment target
- 1
- Study location
NCT07046351: Recruiting NA study of Sugary Beverages, sponsored by University of Virginia.
NCT07046351 is a NA study of Sugary Beverages that is actively recruiting participants, run by University of Virginia. The registered enrollment target is 744 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (47% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07046351, a NA study of Sugary Beverages, is actively recruiting participants, sponsored by University of Virginia.
- RECRUITING
- Registry status
- NA
- Development phase
- 744 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will include 12 rural Head Start programs, randomly assigned to one of two groups: weSIPsmarter vs. control. The main goal is to find out if weSIPsmarter helps reduce sugary drink consumption in preschool-aged children and their parents.
Primary Outcome
The Beverage Intake Questionnaire for Preschool-aged Children (BEVQ-PS) assesses the intake of sugar-sweetened beverages (SSBs) by measuring the frequency and amount (in ounces) across beverage categories. The ounces are then then aggregated to calculate the total SSB intake in ounces.
Conditions Studied
Interventions
- BEHAVIORAL weSIPsmarter
- BEHAVIORAL weLearn2Read
Study Locations (1)
Virginia
- University of Virginia - Christiansburg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 744 participants |
| Start Date | 2025-08-06 |
| Est. Completion | 2029-02-01 |
| Phase | NA |
What NCT07046351 shows while recruiting
NCT07046351 is an interventional study that assigns participants to a tested intervention. The registered 744 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (47% lower).
The record links to 1 condition, with Sugary Beverages appearing as the primary indexed condition, and to 2 interventions - of which weSIPsmarter is the first listed.
NCT07046351 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT07046351 about?
NCT07046351 is a clinical study titled "weSIPsmarter: Evaluating a Digital Health Intervention Aimed at Reducing Sugary Drinks Among Rural Head Start Preschoolers and Their Parents". This study will include 12 rural Head Start programs, randomly assigned to one of two groups: weSIPsmarter vs. control. The main goal is to find out if weSIPsmarter helps reduce sugary drink consumption in preschool-aged children and their parents.
What is the current status of trial NCT07046351?
This trial is currently recruiting. It is a NA study. The enrollment target is 744 participants. The study started on 2025-08-06. Estimated completion is 2029-02-01.
What conditions does trial NCT07046351 study?
This clinical trial studies the following conditions: Sugary Beverages.
What interventions are being tested in trial NCT07046351?
The interventions under investigation include: weSIPsmarter (BEHAVIORAL), weLearn2Read (BEHAVIORAL).
Who is sponsoring clinical trial NCT07046351?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07046351 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sugary Beverages
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07046351's enrollment target sits among peer trials
744 145th of 2000 higher than 1,856 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05619185 · 744 participants · NA
A SMART Evaluation of an Adaptive Web-based AUD Treatment for Service Members and Their Partners
- NCT06417814 · 744 participants · Phase 3
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- NCT07199569 · 744 participants · Phase 2
Comparability Trial of the MVA-BN Vaccine Manufactured in Different Production Cells
- NCT05786417 · 741 participants · Phase 4
LIVEBETTER: A Trial Comparing Medications in Older Adults With Stable Angina and Multiple Chronic Conditions
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI